Myeloperoxidase inhibition in the landscape of anti-inflammatory therapies for heart failure with preserved ejection fraction: the ENDEAVOR trial

Authors: Ambrosy, Andrew P; Ambrosy, Andrew P | Heart Failure Reviews | February 25, 2025 | PubMed abstract

Explore all publications

Back To Top